Title : Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant.

Pub. Date : 2015

PMID : 25677780






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 (90)Y ibritumomab tiuxetan ((90)Y-IT), an anti-CD20 radionuclide-conjugated antibody, has demonstrated clinical efficacy in DLBCL with a favorable toxicity profile. ibritumomab tiuxetan keratin 20 Homo sapiens